
Last Posted: Apr 01, 2021
- Impact of statin therapy on LDL and non-HDL cholesterol levels in subjects with heterozygous familial hypercholesterolaemia.
Climent Elisenda et al. Nutrition, metabolism, and cardiovascular diseases : NMCD 2021 - When do paediatric patients with familial hypercholesterolemia need statin therapy?
Hennig Matylda et al. Journal of mother and child 2021 21(1) 43-50 - Hyperlipidemia: effective disease management with a focus on PCSK9 inhibitors.
Shaw Paul B et al. The American journal of managed care 2021 27(4 Suppl) S63-S69 - A systematic review and meta-analysis of genotype-based and individualized data analysis of SLCO1B1 gene and statin-induced myopathy.
Turongkaravee Saowalak et al. The pharmacogenomics journal 2021 Feb - Cardiovascular Risk Misperception and Low Awareness of Familial Hypercholesterolemia in Individuals with Severe Hypercholesterolemia.
Santos Raul D et al. Arquivos brasileiros de cardiologia 2021 Feb - Cost-Effectiveness of Coronary Artery Calcium Scoring in People With a Family History of Coronary Disease.
Venkataraman Prasanna et al. JACC. Cardiovascular imaging 2021 Jan - Familial hypercholesterolemia in Mexico: Initial insights from the national registry.
Mehta Roopa et al. Journal of clinical lipidology 2020 Dec - Effect of Statins on Renal Function and Total Kidney Volume in Autosomal Dominant Polycystic Kidney Disease.
Xue Cheng et al. Kidney diseases (Basel, Switzerland) 2020 Nov 6(6) 407-413 - Integrated Guidance for Enhancing the Care of Familial Hypercholesterolaemia in Australia.
Watts Gerald F et al. Heart, lung & circulation 2020 Dec - Genetic testing is essential for initiating statin therapy in children with familial hypercholesterolemia: Examples from Scandinavia.
Svendsen Karianne et al. Atherosclerosis 2020 Dec 31648-52
More
Search Result Summary
- CDC Information (1)
- NIH Information (2)
- CDC Publications (0)
- COVID-19 (13)
- Human Genome Epidemiologic Studies (299)
- GWAS Studies (11)
- Human Genomics Translation/Implementation Studies (85)
- Genomic Tests Evidence Synthesis (28)
- Genomic Tests Guidelines (14)
- Tier-Classified Guidelines (9)
- Non-Genomics Precision Health (6)
- Pathogen Advanced Molecular Detection (0)
- State Public Health Genomics Programs (0)
- Ethical/Legal and Social Issues (ELSI) (1)
Quick Links to Other Resources
Disclaimer: Articles listed in the Public Health Genomics and Precision Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Oct 1, 2020
- Page last updated:Apr 26, 2021
- Content source:

